Secukinumab 300 mg demonstrates highest probability of efficacy than other biologics in psoriasis: indirect comparison Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Collins, A
  • Hawe, E
  • Vickers, A
  • Mallya, UG
  • McBride, D
  • Capkun-Niggli, G
  • Olson, M
  • Thorlund, Kristian

publication date

  • May 1, 2015